AASM

Sleep experts call for end of seasonal time changes ahead of ’springing forward‘

Retrieved on: 
Monday, February 26, 2024
Sunshine Protection Act, Stroke, Research, Coalition, Somnolence, Work, National Sleep Foundation, Sleep, Sleep deprivation, Chronobiology, Splenic infarction, Risk, Society, Health, Safety, AASM, Fatigue, Walking, Approximation error, Sleep Research Society, Accident, Senate, American Academy

The American Academy of Sleep Medicine urges policymakers to prioritize the well-being of individuals by abolishing seasonal time changes in favor of permanent standard time.

Key Points: 
  • The American Academy of Sleep Medicine urges policymakers to prioritize the well-being of individuals by abolishing seasonal time changes in favor of permanent standard time.
  • The AASM is joined by members of the Coalition for Permanent Standard Time in this effort to "ditch daylight saving time” and restore permanent standard time.
  • Set clocks ahead one hour in the early evening on March 9 and then go to sleep at your normal bedtime that evening.
  • For more information about daylight saving time and to find additional resources from the AASM about sleep disorders, treatments and sleep health, visit SleepEducation.org .

Los Angeles Center for Ear, Nose, Throat and Allergy Welcomes Sleep Medicine Specialist, Dr. Cyrus Haghighian, M.D. to Practice

Retrieved on: 
Thursday, February 1, 2024
Ear, Narcolepsy, Politics, University, Sleep, Patient, AASM, American Academy, Restless legs syndrome, Nursing

LOS ANGELES, Feb. 1, 2024 /PRNewswire/ -- The Los Angeles Center for Ear, Nose, Throat, and Allergy (LA CENTA) has announced the addition of Dr. Cyrus Haghighian to their practice. Dr. Haghighian is board certified with a robust educational background and extensive training in sleep conditions.

Key Points: 
  • LOS ANGELES, Feb. 1, 2024 /PRNewswire/ -- The Los Angeles Center for Ear, Nose, Throat, and Allergy (LA CENTA) has announced the addition of Dr. Cyrus Haghighian to their practice.
  • With a specialty in Sleep Medicine, Dr. Haghighian strives to help patients achieve better sleep and overall well-being.
  • Plus, his specialty in sleep medicine is a sought-after expertise that we are lucky to be able to offer."
  • To further advance his expertise he went on to pursue a fellowship in Sleep Medicine at the University of Southern California.

Onera raises over €30M in Series C funding

Retrieved on: 
Tuesday, January 16, 2024
Digital health, Sleep, PSG, DACH, Health, Partnership, BOM, ONERA, American Academy, Medicine, Generative grammar, Medtech, Polysomnography, AASM, Growth, Pharmaceutical industry

Onera Health, a leader in sleep diagnostic and monitoring solutions, closed a €30M ($32M) Series C financing round.

Key Points: 
  • Onera Health, a leader in sleep diagnostic and monitoring solutions, closed a €30M ($32M) Series C financing round.
  • Eindhoven – January 16, 2024 – Onera Health, pioneer and leader in remote sleep diagnostic and monitoring solutions enabling clinicians to conduct sleep studies anytime, anywhere, announced the completion of its Series C financing round.
  • This latest funding round brings Onera’s total investment to date to more than €55 million.
  • As part of this transaction, Drew Burdon and Michaël Vlemmix will join Onera Health’s Board of Directors.

Onera raises over €30M in Series C funding

Retrieved on: 
Tuesday, January 16, 2024
Software, General Health, Mobile, Wireless, Hardware, Biometrics, Technology, Medical Devices, Health Technology, Nanotechnology, Neurology, Biotechnology, Wearables, Mobile Technology, Health, Digital health, Sleep, PSG, DACH, Multimedia, Partnership, BOM, ONERA, American Academy, Medicine, Generative grammar, Medtech, Polysomnography, AASM, Growth, Pharmaceutical industry

Onera Health, pioneer and leader in remote sleep diagnostic and monitoring solutions enabling clinicians to conduct sleep studies anytime, anywhere, announced the completion of its Series C financing round.

Key Points: 
  • Onera Health, pioneer and leader in remote sleep diagnostic and monitoring solutions enabling clinicians to conduct sleep studies anytime, anywhere, announced the completion of its Series C financing round.
  • This latest funding round brings Onera’s total investment to date to more than €55 million.
  • View the full release here: https://www.businesswire.com/news/home/20240115279169/en/
    Ruben de Francisco, Founder and CEO of Onera Health.
  • As part of this transaction, Drew Burdon and Michaël Vlemmix will join Onera Health’s Board of Directors.

Data Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance Devices

Retrieved on: 
Tuesday, December 19, 2023
Medicine, Obstructive sleep apnea, Treatment, Multiple, AASM, Master of Science, General Hospital, CPAP, Fatigue, EVO, Doctor of Philosophy, American Academy, BDS, OAT, DMD, ASBA, Patient, Wellness, AHI, Somnolence, Sleep apnea, Jaw, Pharmaceutical industry

PLEASANTON, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA ) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, today announced the publication of a study by the Cureus Journal of Medical Science, in which the Company’s precision oral appliance therapy (OAT) devices successfully treated patients’ OSA.

Key Points: 
  • PLEASANTON, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA ) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, today announced the publication of a study by the Cureus Journal of Medical Science, in which the Company’s precision oral appliance therapy (OAT) devices successfully treated patients’ OSA.
  • 80% of severe OSA patients were treated to an AHI of fewer than 20 events per hour with a 50% improvement.
  • My experience with the ProSomnus® EVO® precision oral appliance is that it exceeds the American Academy of Sleep Medicine (AASM) and the American Academy of Dental Sleep Medicine (AADSM) standards for efficacy.
  • “These studies demonstrate that precision oral devices offer consistent efficacy across multiple clinical and hospital settings, and are associated with reliable adherence.

New position statement supports permanent standard time

Retrieved on: 
Tuesday, October 31, 2023
Journal of Clinical Sleep Medicine, Sleep Research Society, Research, Health, Society for Research on Biological Rhythms, Literature, American Medical Association, Organization, Journal, Chronobiology, Indiana University Health, American Academy, American Academy of Sleep Medicine, Sleep, AASM, Safety, Society, National Sleep Foundation, Nursing care plan, Pharmaceutical industry

DARIEN, Ill., Oct. 31, 2023 (GLOBE NEWSWIRE) -- An updated position statement from the American Academy of Sleep Medicine supports the replacement of daylight saving time with permanent standard time.

Key Points: 
  • DARIEN, Ill., Oct. 31, 2023 (GLOBE NEWSWIRE) -- An updated position statement from the American Academy of Sleep Medicine supports the replacement of daylight saving time with permanent standard time.
  • “Permanent standard time is the optimal choice for health and safety.”
    The position statement was published as an accepted paper Oct. 31 in the Journal of Clinical Sleep Medicine, the official publication of the AASM.
  • The original position statement published by the AASM in 2020 stated that current evidence best supports the adoption of year-round standard time.
  • Based on a growing body of evidence, the updated position statement emphasizes that daylight saving time should be replaced by permanent standard time.

American Academy of Sleep Medicine Launches Initiative to Help Primary Care Professionals Talk to Patients About Sleep

Retrieved on: 
Wednesday, October 25, 2023
AASM, Sleep, Insomnia, Sleep disorder, Social media, American Academy of Sleep Medicine, Patient, Obstructive sleep apnea, Korea Disease Control and Prevention Agency, American Academy, Pharmaceutical industry, Nursing

DARIEN, Ill., Oct. 25, 2023 /PRNewswire/ -- The American Academy of Sleep Medicine (AASM) launches the "Ask One Question" initiative to help primary care professionals talk to their patients about sleep. The effort is part of the AASM's national public education campaign, "Sleep Is Good Medicine," which is increasing awareness of the value and health benefits of healthy sleep.

Key Points: 
  • DARIEN, Ill., Oct. 25, 2023 /PRNewswire/ -- The American Academy of Sleep Medicine (AASM) launches the "Ask One Question" initiative to help primary care professionals talk to their patients about sleep.
  • During audience research that supported the creation of the campaign, the AASM learned that many primary care professionals are hesitant to initiate conversations about sleep with their patients and want resources to help them address their patients' sleep concerns.
  • This insight inspired AASM's new "Ask One Question" initiative, which encourages primary care professionals to start the conversation by asking one simple question during visits: "How is your sleep?"
  • The "Ask One Question" initiative offers resources in English and Spanish to help primary care professionals feel more equipped to talk about sleep with their patients.

Beacon Biosignals Receives FDA Clearance for AI-Assisted Sleep Monitoring Device Dreem 3S

Retrieved on: 
Thursday, September 14, 2023
PSG, AASM, Krystal, Classification, Neurodegenerative disease, Sleep, Clinical trial, Guilloché, American Academy, Atopic dermatitis, Brain, Research, Disorder, Development, Literature, Sleep disorder, Electrode, American Academy of Sleep Medicine, DSM-IV codes, Patient, Machine learning, EEG, Algorithm, Diagnosis, Hospital, FDA, Massachusetts General Hospital, Chronic pain, Psychiatry, Beacon, Neurology, Medical imaging, Pharmaceutical industry

BOSTON, Sept. 14, 2023 /PRNewswire/ -- Beacon Biosignals is thrilled to announce the milestone achievement of FDA 510(k) Clearance for the Dreem 3S, an advanced wearable headband with integrated machine learning algorithms to capture electroencephalogram (EEG) data from the brain to monitor sleep architecture and aid in the diagnosis of disturbed sleep. FDA Clearance marks it as equivalent to in-lab polysomnography for the assessment of sleep staging. The easy-to-use device makes it simple for patients to participate in clinically-validated, EEG-based sleep monitoring at home, unlocking new insights into sleep physiology. Beacon Biosignals, a health technology company whose work focuses on accelerating the development of treatments for neurological, psychiatric, and sleep disorders, acquired the Research and Development business of Dreem in July 2023. The Dreem 3S provides the company yet another asset to provide rich datasets that deepen the understanding of brain activity during sleep.

Key Points: 
  • FDA Clearance marks it as equivalent to in-lab polysomnography for the assessment of sleep staging.
  • The easy-to-use device makes it simple for patients to participate in clinically-validated, EEG-based sleep monitoring at home, unlocking new insights into sleep physiology.
  • Beacon Biosignals, a health technology company whose work focuses on accelerating the development of treatments for neurological, psychiatric, and sleep disorders, acquired the Research and Development business of Dreem in July 2023.
  • The Dreem 3S provides the company yet another asset to provide rich datasets that deepen the understanding of brain activity during sleep.

10th annual Insomnia Awareness Night to drive awareness of chronic insomnia on June 21

Retrieved on: 
Monday, June 19, 2023
AASM, Cognitive behavioral therapy, Society, Type 2 diabetes, Melatonin, Depression, Education, Anxiety, Sleep, Behavioral sleep medicine, American Academy, Insomnia, American Academy of Sleep Medicine, Traffic, Motivation, Somnolence, Irritation, Substance abuse, Health, Fatigue, Nursing

On Wednesday, June 21, the “shortest night of the year,” the AASM will hold the 10th annual Insomnia Awareness Night in collaboration with the Society of Behavioral Sleep Medicine to drive awareness of chronic insomnia and its treatments.

Key Points: 
  • On Wednesday, June 21, the “shortest night of the year,” the AASM will hold the 10th annual Insomnia Awareness Night in collaboration with the Society of Behavioral Sleep Medicine to drive awareness of chronic insomnia and its treatments.
  • Chronic insomnia can be detrimental to physical, mental and emotional health, negatively affecting overall wellness and daily functioning.
  • The first-line recommended treatment for chronic insomnia is cognitive behavioral therapy for insomnia .
  • Since 2014, Insomnia Awareness Night has been held nationally to provide education and support for those living with chronic insomnia.

Avadel Pharmaceuticals Sponsors the Academy of Sleep Medicine Foundation’s 2023 Young Investigators Research Forum

Retrieved on: 
Wednesday, June 14, 2023
AASM, Partnership, Doctor of Pharmacy, Senior, Sleep, American Academy, Research, Avadel Pharmaceuticals, American Academy of Sleep Medicine, MD, Patient, Pharmaceutical industry

DUBLIN, Ireland, June 14, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced leader sponsorship of the American Academy of Sleep Medicine (AASM) Foundation’s 15th Annual Young Investigators Research Forum (YIRF).

Key Points: 
  • DUBLIN, Ireland, June 14, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced leader sponsorship of the American Academy of Sleep Medicine (AASM) Foundation’s 15th Annual Young Investigators Research Forum (YIRF).
  • The AASM Foundation’s YIRF program aids the career development of promising young investigators in clinical and translational sleep medicine research.
  • “At Avadel, we’re passionate about supporting the sleep community, including both people with sleep disorders, as well as scientists advancing sleep research,” said Jennifer Gudeman, PharmD, Senior Vice President, Medical and Clinical Affairs at Avadel.
  • We are thankful for Avadel’s continued support and their sponsorship of this program.”
    To learn more about the Young Investigators Research Forum, please visit: https://foundation.aasm.org/award-programs/young-investigators-research-...